340 related articles for article (PubMed ID: 22241994)
1. Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents.
Olmstead AD; Knecht W; Lazarov I; Dixit SB; Jean F
PLoS Pathog; 2012 Jan; 8(1):e1002468. PubMed ID: 22241994
[TBL] [Abstract][Full Text] [Related]
2. Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents.
Hyrina A; Meng F; McArthur SJ; Eivemark S; Nabi IR; Jean F
PLoS One; 2017; 12(3):e0174483. PubMed ID: 28339489
[TBL] [Abstract][Full Text] [Related]
3. SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection.
Blanchet M; Sureau C; Guévin C; Seidah NG; Labonté P
Antiviral Res; 2015 Mar; 115():94-104. PubMed ID: 25573299
[TBL] [Abstract][Full Text] [Related]
4. The Hepatitis C Virus-induced NLRP3 Inflammasome Activates the Sterol Regulatory Element-binding Protein (SREBP) and Regulates Lipid Metabolism.
McRae S; Iqbal J; Sarkar-Dutta M; Lane S; Nagaraj A; Ali N; Waris G
J Biol Chem; 2016 Feb; 291(7):3254-67. PubMed ID: 26698881
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals.
Hawkins JL; Robbins MD; Warren LC; Xia D; Petras SF; Valentine JJ; Varghese AH; Wang IK; Subashi TA; Shelly LD; Hay BA; Landschulz KT; Geoghegan KF; Harwood HJ
J Pharmacol Exp Ther; 2008 Sep; 326(3):801-8. PubMed ID: 18577702
[TBL] [Abstract][Full Text] [Related]
6. Gene set enrichment analysis reveals several globally affected pathways due to SKI-1/S1P inhibition in HepG2 cells.
De Windt A; Rai M; Bernier L; Thelen K; Soini J; Lefebvre C; Chintawar S; Lavigne J; Saarinen L; Kytömäki L; Munzer JS; Lütjohann D; Pandolfo M; Davignon J; Seidah NG; Laaksonen R
DNA Cell Biol; 2007 Nov; 26(11):765-72. PubMed ID: 17867930
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation.
Syed GH; Tang H; Khan M; Hassanein T; Liu J; Siddiqui A
J Virol; 2014 Mar; 88(5):2519-29. PubMed ID: 24352472
[TBL] [Abstract][Full Text] [Related]
8. Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.
Rojek JM; Pasqual G; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S
J Virol; 2010 Jan; 84(1):573-84. PubMed ID: 19846507
[TBL] [Abstract][Full Text] [Related]
9. The proprotein convertase SKI-1/S1P is a critical host factor for Nairobi sheep disease virus infectivity.
Bost C; Hartlaub J; Pinho Dos Reis V; Strecker T; Seidah NG; Groschup MH; Diederich S; Fischer K
Virus Res; 2023 May; 329():199099. PubMed ID: 36948228
[TBL] [Abstract][Full Text] [Related]
10. SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication.
Blanchet M; Seidah NG; Labonté P
Antiviral Res; 2012 Aug; 95(2):159-66. PubMed ID: 22626636
[TBL] [Abstract][Full Text] [Related]
11. Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation.
Uchida L; Urata S; Ulanday GE; Takamatsu Y; Yasuda J; Morita K; Hayasaka D
Viruses; 2016 Feb; 8(2):. PubMed ID: 26875984
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease.
Burri DJ; Pasqual G; Rochat C; Seidah NG; Pasquato A; Kunz S
J Virol; 2012 May; 86(9):4935-46. PubMed ID: 22357276
[TBL] [Abstract][Full Text] [Related]
13. A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease.
Oppliger J; da Palma JR; Burri DJ; Bergeron E; Khatib AM; Spiropoulou CF; Pasquato A; Kunz S
J Virol; 2016 Jan; 90(2):705-14. PubMed ID: 26512085
[TBL] [Abstract][Full Text] [Related]
14. Recombinant expression, purification, and kinetic and inhibitor characterisation of human site-1-protease.
Bodvard K; Mohlin J; Knecht W
Protein Expr Purif; 2007 Feb; 51(2):308-19. PubMed ID: 16973377
[TBL] [Abstract][Full Text] [Related]
15. Novel circular, cyclic and acyclic Ψ(CH(2)O) containing peptide inhibitors of SKI-1/S1P: synthesis, kinetic and biochemical evaluations.
Majumdar S; Chen A; Palmer-Smith H; Basak A
Curr Med Chem; 2011; 18(18):2770-82. PubMed ID: 21568902
[TBL] [Abstract][Full Text] [Related]
16. Site-1 protease, a novel metabolic target for glioblastoma.
Caruana BT; Skoric A; Brown AJ; Lutze-Mann LH
Biochem Biophys Res Commun; 2017 Aug; 490(3):760-766. PubMed ID: 28645614
[TBL] [Abstract][Full Text] [Related]
17. Reduced sterol regulatory element-binding protein (SREBP) processing through site-1 protease (S1P) inhibition alters oligodendrocyte differentiation in vitro.
Monnerie H; Romer M; Jensen BK; Millar JS; Jordan-Sciutto KL; Kim SF; Grinspan JB
J Neurochem; 2017 Jan; 140(1):53-67. PubMed ID: 27385127
[TBL] [Abstract][Full Text] [Related]
18. Differential recognition of Old World and New World arenavirus envelope glycoproteins by subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P).
Burri DJ; da Palma JR; Seidah NG; Zanotti G; Cendron L; Pasquato A; Kunz S
J Virol; 2013 Jun; 87(11):6406-14. PubMed ID: 23536681
[TBL] [Abstract][Full Text] [Related]
19. Cartilage-specific ablation of site-1 protease in mice results in the endoplasmic reticulum entrapment of type IIb procollagen and down-regulation of cholesterol and lipid homeostasis.
Patra D; DeLassus E; Liang G; Sandell LJ
PLoS One; 2014; 9(8):e105674. PubMed ID: 25147951
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein.
Branche E; Conzelmann S; Parisot C; Bedert L; Lévy PL; Bartosch B; Clément S; Negro F
PLoS One; 2016; 11(1):e0146000. PubMed ID: 26731658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
